<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04841694</url>
  </required_header>
  <id_info>
    <org_study_id>PROB-CAROT</org_study_id>
    <nct_id>NCT04841694</nct_id>
  </id_info>
  <brief_title>Oral Probiotics on the Shift in Gut Microbiome and Skin Carotenoid Levels</brief_title>
  <official_title>Prospective Randomized Double-Blind Placebo Controlled Study of Oral Probiotics on the Shift of Gut Microbiome and Skin Carotenoid Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Integrative Skin Science and Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Microbiome labs</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Integrative Skin Science and Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how probiotics affects circulating carotenoid&#xD;
      levels.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Certain probiotic strains are rich in the production of carotenoids. This study will evaluate&#xD;
      if probiotic supplementation with a carotenoid rich strain will augment circulating&#xD;
      carotenoids.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Carotenoid Levels</measure>
    <time_frame>5 weeks</time_frame>
    <description>Change in skin carotenoid level and blood carotenoid level with supplementation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gut Microbiome Changes</measure>
    <time_frame>Week 5</time_frame>
    <description>Shift in gut microbiome diversity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of GI related gas and constipation</measure>
    <time_frame>Week 5</time_frame>
    <description>self assessment using digestive health questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of GI related gas and constipation</measure>
    <time_frame>Week 6</time_frame>
    <description>self assessment using digestive health questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shift in facial redness- image based</measure>
    <time_frame>Week 5</time_frame>
    <description>BTBP Clarity Mini 3D camera</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shift in facial redness- image based</measure>
    <time_frame>Week 6</time_frame>
    <description>BTBP Clarity Mini 3D camera</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shift in facial pigmentation - image based</measure>
    <time_frame>Week 5</time_frame>
    <description>BTBP Clarity Mini 3D camera</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shift in facial pigmentation - image based</measure>
    <time_frame>Week 6</time_frame>
    <description>BTBP Clarity Mini 3D camera</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Protection against blue light exposure induced change in skin color</measure>
    <time_frame>Weeks 5</time_frame>
    <description>Change in skin color measured by a skin colorimeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Protection against blue light exposure induced change in skin color</measure>
    <time_frame>Weeks 6</time_frame>
    <description>Change in skin color measured by a skin colorimeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carotenoid Levels</measure>
    <time_frame>5 weeks</time_frame>
    <description>Change in skin carotenoid level and blood carotenoid level with supplementation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Human Microbiome</condition>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be taking a probiotic supplement that they will be taking by mouth once per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic</intervention_name>
    <description>Bacillus indicus</description>
    <arm_group_label>Probiotic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects aged 40+&#xD;
&#xD;
          -  Must be willing to comply with all protocol requirements&#xD;
&#xD;
          -  Must be willing to have flash photo facial images taken with the imaging systems&#xD;
&#xD;
          -  Fitzpatrick skin type II, III, or IV&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any systemic or antibiotics (injected or oral) within 6 months of starting study&#xD;
&#xD;
          -  Any topical antibiotic or Vitamin A within 1 month of starting study or any subject&#xD;
             unwilling to refrain from washout of topical antibacterial or vitamin A ingredient.&#xD;
&#xD;
          -  Any oral probiotic or prebiotic supplementation within past 1 month at the discretion&#xD;
             of the investigator.&#xD;
&#xD;
          -  Limit total fruit and vegetable intake to 2.5 servings (1 serving=1 cup) per day of&#xD;
             high carotenoid foods. High carotenoid foods include spinach, summer squash, carrots,&#xD;
             citrus fruits, celery, kale, tomatoes, and cantaloupe&#xD;
&#xD;
          -  Subjects must have no history of malignancy or cancer (excluding skin cancer unless&#xD;
             there is a history of metastasis) or diagnosis of gastrointestinal inflammatory&#xD;
             diseases, no history or diagnosis of epilepsy, no history or diagnosis of immunologic&#xD;
             or infectious disease (e.g. hepatitis, tuberculosis, HIV or AIDS, lupus, rheumatoid&#xD;
             arthritis)&#xD;
&#xD;
          -  Has a condition or is on medication the investigator and/or designee believe could&#xD;
             jeopardize the safety of the subject, interfere with the evaluation, or confound the&#xD;
             interpretation of the study results&#xD;
&#xD;
          -  Women who have been pregnant in the last three months, are pregnant, preparing to be&#xD;
             pregnant or lactating.&#xD;
&#xD;
          -  Is participating in a concurrent intervention based clinical research study&#xD;
&#xD;
          -  Those with BMI higher than 35 kg/mÂ²&#xD;
&#xD;
          -  Commencement of a new diet (such as the ketogenic diet) or supplements within the 1&#xD;
             month prior to initiating participation, at the discretion of the investigator.&#xD;
&#xD;
          -  Is participating in or has participated in a intervention based facial study at this&#xD;
             or any other facility in the past 2 weeks. Participation in survey-based studies are&#xD;
             approved at the discretion of the investigator.&#xD;
&#xD;
          -  Has a skin disease on face that will interfere with image collection and assessment in&#xD;
             the opinion of the investigator&#xD;
&#xD;
          -  Refusal to shave or remove facial hair that may interfere with image collection and&#xD;
             assessment.&#xD;
&#xD;
          -  Persons unwilling to avoid the following during the 4 weeks prior and during the&#xD;
             duration of the study: self-tanning, spa tanning, sun tanning, or artificial tanning.&#xD;
&#xD;
          -  Known allergy or irritation to the supplement utilized in the study&#xD;
&#xD;
          -  Persons unwilling to avoid sun exposure to the inner forearm&#xD;
&#xD;
          -  Current tobacco smokers, OR those that have smoked tobacco over the past year, OR a 5&#xD;
             year-pack year history of smoking tobacco&#xD;
&#xD;
          -  Cutaneous photosensitivity at wavelengths of 400-450 nm&#xD;
&#xD;
          -  Porphyria or known allergies to porphyrins&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Adults unable to consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Raja K Sivamani, MD</last_name>
    <phone>916-524-1216</phone>
    <email>raja.sivamani@integrativeskinresearch.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Integrative Skin Science and Research</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95815</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Raja K Sivamani, MD</last_name>
      <phone>916-524-1216</phone>
      <email>raja.sivamani@integrativeskinresearch.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 5, 2021</study_first_submitted>
  <study_first_submitted_qc>April 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Integrative Skin Science and Research</investigator_affiliation>
    <investigator_full_name>Raja Sivamani</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>gut microbiome</keyword>
  <keyword>dermatology</keyword>
  <keyword>skin</keyword>
  <keyword>carotenoids</keyword>
  <keyword>probiotics</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

